349 related articles for article (PubMed ID: 33919596)
1. An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma.
Lyne SB; Yamini B
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33919596
[TBL] [Abstract][Full Text] [Related]
2. Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery-A Comprehensive Review of the Literature.
Alomari S; Zhang I; Hernandez A; Kraft CY; Raj D; Kedda J; Tyler B
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944514
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral Drug Repositioning for Glioblastoma.
Rivas SR; Mendez Valdez MJ; Chandar JS; Desgraves JF; Lu VM; Ampie L; Singh EB; Seetharam D; Ramsoomair CK; Hudson A; Ingle SM; Govindarajan V; Doucet-O'Hare TT; DeMarino C; Heiss JD; Nath A; Shah AH
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730705
[TBL] [Abstract][Full Text] [Related]
4. Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma.
Persico M; Abbruzzese C; Matteoni S; Matarrese P; Campana AM; Villani V; Pace A; Paggi MG
Cells; 2022 Jan; 11(2):. PubMed ID: 35053377
[TBL] [Abstract][Full Text] [Related]
5. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Orphanet J Rare Dis; 2023 Sep; 18(1):301. PubMed ID: 37749605
[TBL] [Abstract][Full Text] [Related]
6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
7. Repurposing antipsychotics as glioblastoma therapeutics: Potentials and challenges.
Lee JK; Nam DH; Lee J
Oncol Lett; 2016 Feb; 11(2):1281-1286. PubMed ID: 26893731
[TBL] [Abstract][Full Text] [Related]
8. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.
Hernandez JJ; Pryszlak M; Smith L; Yanchus C; Kurji N; Shahani VM; Molinski SV
Front Oncol; 2017; 7():273. PubMed ID: 29184849
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
10. Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.
Malla R; Viswanathan S; Makena S; Kapoor S; Verma D; Raju AA; Dunna M; Muniraj N
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672545
[TBL] [Abstract][Full Text] [Related]
11. Repurposed agents in the Alzheimer's disease drug development pipeline.
Bauzon J; Lee G; Cummings J
Alzheimers Res Ther; 2020 Aug; 12(1):98. PubMed ID: 32807237
[TBL] [Abstract][Full Text] [Related]
12. Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond.
Daisy Precilla S; Kuduvalli SS; Thirugnanasambandhar Sivasubramanian A
Cell Biol Int; 2021 Jan; 45(1):18-53. PubMed ID: 33049091
[TBL] [Abstract][Full Text] [Related]
13. Drug Repositioning in Glioblastoma: A Pathway Perspective.
Tan SK; Jermakowicz A; Mookhtiar AK; Nemeroff CB; Schürer SC; Ayad NG
Front Pharmacol; 2018; 9():218. PubMed ID: 29615902
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia.
Johanssen T; McVeigh L; Erridge S; Higgins G; Straehla J; Frame M; Aittokallio T; Carragher NO; Ebner D
Front Oncol; 2022; 12():1075559. PubMed ID: 36733367
[TBL] [Abstract][Full Text] [Related]
15. Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma.
Harder BG; Blomquist MR; Wang J; Kim AJ; Woodworth GF; Winkles JA; Loftus JC; Tran NL
Front Oncol; 2018; 8():462. PubMed ID: 30406029
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Profiling of a Patient-Matched Cohort of Glioblastoma (IDH-Wildtype) for Therapeutic Target and Repurposing Drug Identification.
Roddy AC; McInerney CE; Flannery T; Healy EG; Stewart JP; Spence VJ; Walsh J; Salto-Tellez M; McArt DG; Prise KM
Biomedicines; 2023 Apr; 11(4):. PubMed ID: 37189838
[TBL] [Abstract][Full Text] [Related]
17. Treatment of elderly patients with glioblastoma: a systematic evidence-based analysis.
Zarnett OJ; Sahgal A; Gosio J; Perry J; Berger MS; Chang S; Das S
JAMA Neurol; 2015 May; 72(5):589-96. PubMed ID: 25822375
[TBL] [Abstract][Full Text] [Related]
18. Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma.
Ntafoulis I; Koolen SLW; Leenstra S; Lamfers MLM
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954371
[TBL] [Abstract][Full Text] [Related]
19. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
20. Integrative Rare Disease Biomedical Profile based Network Supporting Drug Repurposing, a case study of Glioblastoma.
McGowan E; Sanjak J; Mathé EA; Zhu Q
Res Sq; 2023 Apr; ():. PubMed ID: 37131675
[No Abstract] [Full Text] [Related]
[Next] [New Search]
